J1730 Injection, diazoxide, up to 300 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Diazoxide injection
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, diazoxide, up to 300 mg | yes |
Related codes in J17
- J1700 Injection, hydrocortisone acetate, up to 25 mg
- J1720 Injection, hydrocortisone sodium succinate, up to 100 mg
- J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729 Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1736 Injection, meloxicam (delova), 1 mg
- J1737 Injection, meloxicam (azurity), 1 mg
- J1738 Injection, meloxicam, 1 mg
- J1740 Injection, ibandronate sodium, 1 mg
- J1741 Injection, ibuprofen, 100 mg
- J1742 Injection, ibutilide fumarate, 1 mg
- J1743 Injection, idursulfase, 1 mg
- J1744 Injection, icatibant, 1 mg
- J1745 Injection, infliximab, excludes biosimilar, 10 mg
- J1746 Injection, ibalizumab-uiyk, 10 mg
- J1747 Injection, spesolimab-sbzo, 1 mg
- J1748 Injection, infliximab-dyyb (zymfentra), 10 mg
- J1749 Injection, iloprost, 0.1 mcg
- J1750 Injection, iron dextran, 50 mg
- J1756 Injection, iron sucrose, 1 mg
- J1786 Injection, imiglucerase, 10 units